273 related articles for article (PubMed ID: 33933989)
1. Morin attenuates pyroptosis of nucleus pulposus cells and ameliorates intervertebral disc degeneration via inhibition of the TXNIP/NLRP3/Caspase-1/IL-1β signaling pathway.
Zhou Y; Chen Z; Yang X; Cao X; Liang Z; Ma H; Zhao J
Biochem Biophys Res Commun; 2021 Jun; 559():106-112. PubMed ID: 33933989
[TBL] [Abstract][Full Text] [Related]
2. Propionibacterium acnes induces intervertebral disc degeneration by promoting nucleus pulposus cell pyroptosis via NLRP3-dependent pathway.
He D; Zhou M; Bai Z; Wen Y; Shen J; Hu Z
Biochem Biophys Res Commun; 2020 Jun; 526(3):772-779. PubMed ID: 32265028
[TBL] [Abstract][Full Text] [Related]
3. Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis.
Gong Y; Qiu J; Jiang T; Li Z; Zhang W; Zheng X; He Z; Chen W; Wang Z; Feng X; Wang M; Hong Z
Inflammopharmacology; 2023 Feb; 31(1):369-384. PubMed ID: 36401729
[TBL] [Abstract][Full Text] [Related]
4. Honokiol alleviates the degeneration of intervertebral disc via suppressing the activation of TXNIP-NLRP3 inflammasome signal pathway.
Tang P; Gu JM; Xie ZA; Gu Y; Jie ZW; Huang KM; Wang JY; Fan SW; Jiang XS; Hu ZJ
Free Radic Biol Med; 2018 May; 120():368-379. PubMed ID: 29649568
[TBL] [Abstract][Full Text] [Related]
5. Acid-sensing ion channels regulate nucleus pulposus cell inflammation and pyroptosis via the NLRP3 inflammasome in intervertebral disc degeneration.
Zhao K; An R; Xiang Q; Li G; Wang K; Song Y; Liao Z; Li S; Hua W; Feng X; Wu X; Zhang Y; Das A; Yang C
Cell Prolif; 2021 Jan; 54(1):e12941. PubMed ID: 33111436
[TBL] [Abstract][Full Text] [Related]
6. The involvement of DDX3X in compression-induced nucleus pulposus pyroptosis.
Chi S; Li S; Xu Z; Yang G; Song Y; Liao Z; Yang C; Wu X
Biochem Biophys Res Commun; 2023 May; 655():1-10. PubMed ID: 36907112
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin inhibits LPS-induced nucleus pulposus cell pyroptosis through the miR-135a-5p/TXNIP signaling pathway.
Wu S; Liu S; Huang R; Zhou Y; Zou Y; Yang W; Zhang J
Aging (Albany NY); 2023 Dec; 15(23):13680-13692. PubMed ID: 38048212
[TBL] [Abstract][Full Text] [Related]
8.
Tang G; Han X; Lin Z; Qian H; Chen B; Zhou C; Chen Y; Jiang W
Oxid Med Cell Longev; 2021; 2021():4657014. PubMed ID: 33603947
[TBL] [Abstract][Full Text] [Related]
9. Verapamil attenuates intervertebral disc degeneration by suppressing ROS overproduction and pyroptosis via targeting the Nrf2/TXNIP/NLRP3 axis in four-week puncture-induced rat models both in vivo and in vitro.
Chen Y; Cao X; Pan B; Du H; Li B; Yang X; Chen X; Wang X; Zhou T; Qin A; Zhao C; Zhao J
Int Immunopharmacol; 2023 Oct; 123():110789. PubMed ID: 37579541
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells.
Song Y; Wang Y; Zhang Y; Geng W; Liu W; Gao Y; Li S; Wang K; Wu X; Kang L; Yang C
J Cell Mol Med; 2017 Jul; 21(7):1373-1387. PubMed ID: 28224704
[TBL] [Abstract][Full Text] [Related]
11. MINK1 deficiency stimulates nucleus pulposus cell pyroptosis and exacerbates intervertebral disc degeneration.
Zhan K; Zhu K; Gu B; Yao S; Fu F; Zeng H; Tian K; Ji W; Jin H; Tong P; Wu C; Yue M; Ruan H
Int Immunopharmacol; 2024 Jun; 134():112202. PubMed ID: 38723371
[TBL] [Abstract][Full Text] [Related]
12. Platelet-rich plasma attenuates intervertebral disc degeneration via delivering miR-141-3p-containing exosomes.
Xu J; Xie G; Yang W; Wang W; Zuo Z; Wang W
Cell Cycle; 2021 Aug; 20(15):1487-1499. PubMed ID: 34229586
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 alleviates IL-1β induced nucleus pulposus cells pyroptosis via mitophagy in intervertebral disc degeneration.
Ma Z; Tang P; Dong W; Lu Y; Tan B; Zhou N; Hao J; Shen J; Hu Z
Int Immunopharmacol; 2022 Jun; 107():108671. PubMed ID: 35305383
[TBL] [Abstract][Full Text] [Related]
14. Enhanced NLRP3, caspase-1, and IL- 1β levels in degenerate human intervertebral disc and their association with the grades of disc degeneration.
Chen ZH; Jin SH; Wang MY; Jin XL; Lv C; Deng YF; Wang JL
Anat Rec (Hoboken); 2015 Apr; 298(4):720-6. PubMed ID: 25284686
[TBL] [Abstract][Full Text] [Related]
15. Gamma-oryzanol alleviates intervertebral disc degeneration development by intercepting the IL-1β/NLRP3 inflammasome positive cycle.
Xu H; Dai ZH; He GL; Cai HC; Chen XY; Chen YL; Xu C; Sheng SR
Phytomedicine; 2022 Jul; 102():154176. PubMed ID: 35660354
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IRE1 suppresses the catabolic effect of IL-1β on nucleus pulposus cell and prevents intervertebral disc degeneration in vivo.
Kang H; Dong Y; Peng R; Liu H; Guo Q; Song K; Zhu M; Yu K; Wu W; Li F
Biochem Pharmacol; 2022 Mar; 197():114932. PubMed ID: 35085541
[TBL] [Abstract][Full Text] [Related]
17. BMP7 ameliorates intervertebral disc degeneration in type 1 diabetic rats by inhibiting pyroptosis of nucleus pulposus cells and NLRP3 inflammasome activity.
Yu XJ; Wang YG; Lu R; Guo XZ; Qu YK; Wang SX; Xu HR; Kang H; You HB; Xu Y
Mol Med; 2023 Mar; 29(1):30. PubMed ID: 36858954
[TBL] [Abstract][Full Text] [Related]
18. Ephrin B2 (EFNB2) potentially protects against intervertebral disc degeneration through inhibiting nucleus pulposus cell apoptosis.
Zhang Q; Li J; Liu F; Hu J; Liu F; Zou J; Wang X
Arch Biochem Biophys; 2024 Jun; 756():109990. PubMed ID: 38636690
[TBL] [Abstract][Full Text] [Related]
19. Cortistatin protects against intervertebral disc degeneration through targeting mitochondrial ROS-dependent NLRP3 inflammasome activation.
Zhao Y; Qiu C; Wang W; Peng J; Cheng X; Shangguan Y; Xu M; Li J; Qu R; Chen X; Jia S; Luo D; Liu L; Li P; Guo F; Vasilev K; Liu L; Hayball J; Dong S; Pan X; Li Y; Guo L; Cheng L; Li W
Theranostics; 2020; 10(15):7015-7033. PubMed ID: 32550919
[No Abstract] [Full Text] [Related]
20. Ligustilide alleviated IL-1β induced apoptosis and extracellular matrix degradation of nucleus pulposus cells and attenuates intervertebral disc degeneration in vivo.
Wang K; Chen T; Ying X; Zhang Z; Shao Z; Lin J; Xu T; Chen Y; Wang X; Chen J; Sheng S
Int Immunopharmacol; 2019 Apr; 69():398-407. PubMed ID: 30785069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
